FABP1 anticorps

N° du produit ABIN2191917

Détail du produit anti-FABP1 anticorps

Antigène: FABP1 (Fatty Acid Binding Protein 1, Liver (FABP1))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp FABP1 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS), Immunoassay (IA)

Réactivité croisée (Details): Cross reactivity: : Baboon L-FABP : Yes, Dog L-FABP : Yes, Rat L-FABP : Yes, Swine L-FABP : Yes, Human H-FABP Weak

Stérilité: 0.2 μm filtered

Clone: L2B10

Isotype: IgG2b

Information d'application

Indications d'application: For immunohistology and Western blotting, dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:50.

Restrictions: For Research Use only

Stockage

Buffer: PBS, containing 0.1 % bovine serum albumin and 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Stockage commentaire: Product should be stored at 4 °C. Under recommended storage conditions, product is stable for one year.

Date de péremption: 12 months

Références pour anticorps anti-FABP1 (ABIN2191917)

Bax, Siersema, Haringsma, Kuipers, Vos, Van Dekken, Van Vliet, Kusters: "High-grade dysplasia in Barrett's esophagus is associated with increased expression of calgranulin A and B." dans: Scandinavian journal of gastroenterology, Vol. 42, Issue 8, pp. 902-10, (2007) (PubMed).

Détails sur FABP1

Antigène: FABP1 (Fatty Acid Binding Protein 1, Liver (FABP1))

Autre désignation: Liver Fatty Acid Binding Protein (FABP1 Produits)

Synonymes: anticorps FABPL, anticorps L-FABP, anticorps KAT4, anticorps KATIV, anticorps mitAAT, anticorps Fabpl, anticorps Fabplg, anticorps SCP, anticorps SCP., anticorps p14, anticorps FABP1, anticorps FABP, anticorps LFABP, anticorps liver, anticorps fabp1, anticorps Fabp1, anticorps FABP-1, anticorps FABPpm, anticorps mAspAT, anticorps fatty acid binding protein 1, anticorps glutamic-oxaloacetic transaminase 2, anticorps fatty acid binding protein 1, liver, anticorps fatty acid binding protein 1a, liver, anticorps fatty acid-binding protein, liver, anticorps FABP1, anticorps GOT2, anticorps Fabp1, anticorps fabp1a, anticorps LOC100726384

Sujet: The monoclonal antibody L2B10 recognizes human liver fatty acid binding protein (L-FABP) of both natural and recombinant origin. The L-FABP protein is derived from the human FABP1 gene. FABPs are small intracellular proteins (~13-14 kDa) with a high degree of tissue specificity that bind long chain fatty acids. They are abundantly present in various cell types and play an important role in the intracellular utilization of fatty acids, transport and metabolism. There are at least nine distinct types of FABP, each showing a specific pattern of tissue expression. Due to its small size, FABP leaks rapidly out of ischemically damaged necrotic cells leading to a rise in serum levels. Ischemically damaged tissues are characterized histologically by absence (or low presence) of FABP facilitating recognition of such areas. L-FABP is localized in the liver, kidney and intestinal epithelium. The monoclonal antibody L2B10 is useful to detect ischemic areas of human liver. Furthermore, the antibody can be used for the purification of human L-FABP. Aliases FABP1

Pathways: Chromatin Binding, Regulation of Lipid Metabolism by PPARalpha